login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
TELA BIO INC (TELA) Stock News
USA
- NASDAQ:TELA -
US8723811084
-
Common Stock
1.14
USD
-0.05 (-4.2%)
Last: 11/12/2025, 4:04:06 PM
1.24
USD
+0.1 (+8.77%)
After Hours:
11/5/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
TELA Latest News, Press Relases and Analysis
All
Press Releases
11 hours ago - By: Zacks Investment Research
- Mentions:
HUMA
Humacyte, Inc. (HUMA) Reports Q3 Loss, Misses Revenue Estimates
7 days ago - By: Zacks Investment Research
- Mentions:
CTKB
Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates
8 days ago - By: TELA Bio, Inc.
TELA Bio to Announce Third Quarter 2025 Financial Results
8 days ago - By: TELA Bio, Inc.
TELA Bio to Announce Third Quarter 2025 Financial Results
9 days ago - By: TELA Bio, Inc.
TELA Bio Appoints William Plovanic to Board of Directors
3 months ago - By: TELA Bio, Inc.
TELA Bio Reports Second Quarter 2025 Financial Results
3 months ago - By: TELA Bio, Inc.
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
4 months ago - By: TELA Bio, Inc.
TELA Bio to Announce Second Quarter 2025 Financial Results
a month ago - By: TELA Bio, Inc.
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
a month ago - By: TELA Bio, Inc.
TELA Bio Announces Addition of Betty Jo Rocchio to Board of Directors and the Departure of Director Lisa Colleran
3 months ago - By: Benzinga
- Mentions:
SNGX
VKTX
PPCB
XFOR
...
12 Health Care Stocks Moving In Tuesday's Intraday Session
3 months ago - By: Zacks Investment Research
- Mentions:
ADCT
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
3 months ago - By: Benzinga
- Mentions:
EQ
AZTR
FGEN
MYO
...
12 Health Care Stocks Moving In Monday's After-Market Session
5 months ago - By: TELA Bio, Inc.
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: TELA Bio, Inc.
TELA Bio Appoints Jeffrey Blizard as President
6 months ago - By: TELA Bio, Inc.
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: TELA Bio, Inc.
TELA Bio Reports Second Quarter 2025 Financial Results
7 months ago - By: TELA Bio, Inc.
TELA Bio to Announce First Quarter 2025 Financial Results
3 months ago - By: TELA Bio, Inc.
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
3 months ago - By: Zacks Investment Research
- Mentions:
PRME
Prime Medicine, Inc. (PRME) Reports Q2 Loss, Lags Revenue Estimates
3 months ago - By: Zacks Investment Research
- Mentions:
GERN
Geron (GERN) Reports Q2 Loss, Tops Revenue Estimates
4 months ago - By: TELA Bio, Inc.
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
4 months ago - By: TELA Bio, Inc.
TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference
4 months ago - By: TELA Bio, Inc.
TELA Bio to Announce Second Quarter 2025 Financial Results
5 months ago - By: TELA Bio, Inc.
TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
5 months ago - By: TELA Bio, Inc.
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
5 months ago - By: TELA Bio, Inc.
TELA Bio Announces European Commercial Launch of OviTex® Inguinal for Robotic and Laparoscopic Inguinal Hernia Repair
5 months ago - By: TELA Bio, Inc.
TELA Bio Appoints Jeffrey Blizard as President
6 months ago - By: TELA Bio, Inc.
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
6 months ago - By: TELA Bio, Inc.
TELA Bio to Participate in the 2025 Jefferies Global Healthcare Conference
6 months ago - By: TELA Bio, Inc.
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
6 months ago - By: Zacks Investment Research
- Mentions:
ETON
TELA Bio, Inc. (TELA) Reports Q1 Loss, Tops Revenue Estimates
6 months ago - By: TELA Bio, Inc.
TELA Bio Reports First Quarter 2025 Financial Results
7 months ago - By: TELA Bio, Inc.
TELA Bio to Announce First Quarter 2025 Financial Results
8 months ago - By: TELA Bio, Inc.
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
8 months ago - By: TELA Bio, Inc.
TELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive Surgery
Please enable JavaScript to continue using this application.